PL374481A1 - Środek do leczenia cukrzycy - Google Patents

Środek do leczenia cukrzycy

Info

Publication number
PL374481A1
PL374481A1 PL03374481A PL37448103A PL374481A1 PL 374481 A1 PL374481 A1 PL 374481A1 PL 03374481 A PL03374481 A PL 03374481A PL 37448103 A PL37448103 A PL 37448103A PL 374481 A1 PL374481 A1 PL 374481A1
Authority
PL
Poland
Prior art keywords
ghs
antagonist
active ingredient
prophylactic
therapeutic
Prior art date
Application number
PL03374481A
Other languages
English (en)
Inventor
Akio Inui
Akihiro Asakawa
Original Assignee
Chugai Seiyaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Seiyaku Kabushiki Kaisha filed Critical Chugai Seiyaku Kabushiki Kaisha
Publication of PL374481A1 publication Critical patent/PL374481A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Mirrors, Picture Frames, Photograph Stands, And Related Fastening Devices (AREA)
  • External Artificial Organs (AREA)
PL03374481A 2002-07-05 2003-07-03 Środek do leczenia cukrzycy PL374481A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002197582 2002-07-05

Publications (1)

Publication Number Publication Date
PL374481A1 true PL374481A1 (pl) 2005-10-31

Family

ID=30112403

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03374481A PL374481A1 (pl) 2002-07-05 2003-07-03 Środek do leczenia cukrzycy

Country Status (15)

Country Link
US (1) US20060276381A1 (pl)
EP (1) EP1541171B1 (pl)
JP (1) JP5113320B2 (pl)
KR (1) KR20050039829A (pl)
CN (1) CN1681532A (pl)
AT (1) ATE481133T1 (pl)
AU (1) AU2003246261A1 (pl)
BR (1) BR0312463A (pl)
CA (1) CA2493906A1 (pl)
DE (1) DE60334225D1 (pl)
ES (1) ES2351856T3 (pl)
MX (1) MXPA05000160A (pl)
PL (1) PL374481A1 (pl)
RU (1) RU2005102923A (pl)
WO (1) WO2004004772A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4843827B2 (ja) * 2005-02-23 2011-12-21 国立大学法人京都大学 膵臓β細胞の再生促進剤及び膵臓β細胞におけるインスリン産生促進剤
EP2021015A2 (en) 2006-04-28 2009-02-11 The Administrators Of The Tulane Educational Fund Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
KR20090119785A (ko) 2007-03-12 2009-11-19 유키지루시 뉴교 가부시키가이샤 성장 호르몬 분비 촉진제
CN101951937A (zh) * 2007-12-21 2011-01-19 赫尔辛医疗股份公司 使用伊帕瑞林刺激胃肠系统动力的方法
WO2010022213A2 (en) * 2008-08-22 2010-02-25 Elixir Pharmaceuticals, Inc. Compositions and methods for preserving pancreatic islet mass
US9724381B2 (en) 2009-05-12 2017-08-08 The Administrators Of The Tulane Educational Fund Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
CN102639700A (zh) 2009-09-30 2012-08-15 哈佛大学校长及研究员协会 通过调节自噬增强基因产物调节自噬的方法
US20110105389A1 (en) 2009-10-30 2011-05-05 Hoveyda Hamid R Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010020012A1 (en) * 2000-02-01 2001-09-06 Andersen Maibritt Bansholm Use of compounds for the regulation of food intake
AU2001228325A1 (en) * 2000-02-01 2001-08-14 Novo-Nordisk A/S Use of compounds for the regulation of food intake
EP1286697A2 (en) * 2000-05-17 2003-03-05 Eli Lilly And Company Method for selectively inhibiting ghrelin action
CA2411667A1 (en) * 2000-05-30 2001-12-06 Merck & Co. Inc. Ghrelin analogs
JP4493913B2 (ja) * 2001-01-31 2010-06-30 中外製薬株式会社 低栄養症状疾患治療剤
US6949261B2 (en) * 2002-11-12 2005-09-27 Ayurvedic-Life International, Llc Compositions for diabetes treatment and prophylaxis

Also Published As

Publication number Publication date
US20060276381A1 (en) 2006-12-07
MXPA05000160A (es) 2006-02-28
KR20050039829A (ko) 2005-04-29
EP1541171A1 (en) 2005-06-15
JPWO2004004772A1 (ja) 2005-11-04
WO2004004772A1 (ja) 2004-01-15
ATE481133T1 (de) 2010-10-15
DE60334225D1 (de) 2010-10-28
CA2493906A1 (en) 2004-01-15
ES2351856T3 (es) 2011-02-11
CN1681532A (zh) 2005-10-12
EP1541171A4 (en) 2008-04-09
EP1541171B1 (en) 2010-09-15
BR0312463A (pt) 2005-04-26
AU2003246261A1 (en) 2004-01-23
RU2005102923A (ru) 2005-10-10
JP5113320B2 (ja) 2013-01-09

Similar Documents

Publication Publication Date Title
ZA200706021B (en) 1-thio-D-glucitol derivatives
WO2002081453A8 (fr) Hiohydantoïnes et leur utilisation dans le traitement du diabete
NO20060908L (no) Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse
EG24124A (en) Pharmaceutical compositions for the treatment of type-II diabetes mellitus
WO2004072031A3 (en) Phenylacetamides and their use as glucokinase modulators
MXPA05009508A (es) Derivados de nicotinamida 6-substituida como antagonistas de receptor opioide.
HUP0303876A3 (en) Preparation of pharmaceutical compositions for treatment of type 2 diabetes using piperidine or tiazolidine, inhibitors of dipeptidyl peptidase iv
NO20072389L (no) Substituerte benzokinolizinderivater
TNSN06315A1 (en) Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of type 2 diabetes
NO20055680L (no) Heksahydropyridoisokinoliner som DPP-IV-inhibitorer
NO20055887L (no) Pyrido'2, 1-A-isokinoliderivater som DPP-IV-inhibitorer
WO2005044192A3 (en) Triazole compounds and uses related thereto
WO2005051325A3 (en) Carvedilol compositions methods of treatment and delivery
NO20065926L (no) Substituerte oksazolbenzoisotiazoldioksidderivater samt fremgangsmate for fremstilling og anvendelse derav
WO2007065808A3 (en) Neuropeptide-2 receptor-agonists
WO2008136392A1 (ja) 経口投与用製剤
EP1619180A4 (en) CASR ANTAGONIST
DE602006009095D1 (en) Diacylglycerol-acyltransferase-hemmer
IL179599A0 (en) Glucagon receptor antagonists, preparation and therapeutic uses
DE60302157D1 (de) Opioidrezeptorantagonisten
WO2002042271A3 (en) Biphenylcarboxamides useful as lipid lowering agents
WO2005082893A3 (en) Histamine h3 receptor antagonists, preparation and therapeutic uses
WO2006052889A3 (en) Quinolinone-carboxamide compounds
JO2390B1 (en) Diphenylcarboxamides act as lipid-lowering agents
ATE481133T1 (de) Mittel zum senken des blutglukosespiegels

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)